Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Movicol for chronic constipation in children
NCT00403819Phase 3Completed
- Sponsor
- Norgine
- Start
- Apr 2002
- Modality
- Polymer-based Nanoparticles
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic constipation comparing Movicol First with Placebo First (2 arms). Primary endpoint: Mean number of complete defaecations per week. Started Apr 2002; status: completed.
02
Drugs
polyethylene glycol
03
Conditions
chronic constipation
Beyond the preview
Go deeper on NCT00403819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00403819.